Global Fertility Testing Devices Market Synopsis

Global Fertility Testing Devices Market Size Was Valued at USD 659.09 Million In 2022 And Is Projected to Reach USD 1099.01 Million By 2030, Growing at A CAGR of 6.6% From 2022 To 2030.

Fertility Testing Devices refer to a diverse range of medical instruments, tools, and kits designed to assess and monitor an individual's reproductive health and fertility potential. These devices are crucial for both men and women who are trying to conceive, as they provide valuable insights into various aspects of fertility, aiding in family planning and addressing infertility issues.

  • For women, fertility testing devices commonly include ovulation prediction kits and monitors. Ovulation prediction kits detect the surge in luteinizing hormone (LH) that occurs just before ovulation, helping women identify their most fertile days. Ovulation monitors, on the other hand, track hormonal changes throughout the menstrual cycle, offering a more comprehensive understanding of fertility patterns.
  • Men can benefit from male fertility test kits, which assess sperm quality and quantity. These kits often include tools for collecting semen samples and analyzing parameters such as sperm count, motility, and morphology. Understanding these factors is vital for assessing male fertility and addressing potential issues.
  • In recent years, there has been a significant advancement in digital and smartphone-connected fertility testing devices. These innovations allow users to track their fertility using mobile apps and wearable devices, making the process more convenient and data-driven. Such devices offer personalized insights, predict fertile windows, and store historical data for long-term fertility monitoring.

Global Fertility Testing Devices Market Trend Analysis

Increasing first-time pregnancy age

  • The trend of increasing first-time pregnancy age has become a prominent factor driving the growth of the Fertility Testing Devices Market. Societal shifts, evolving career aspirations, and the desire for financial stability have led individuals, especially women, to delay starting a family. As a result, there's a growing demand for fertility testing devices among couples planning to conceive later in life.
  • These devices cater to individuals seeking greater control and understanding of their reproductive health. They offer convenience by allowing users to monitor fertility indicators at home, such as ovulation prediction kits and fertility tracking apps. The accessibility and privacy these tools provide align perfectly with the preferences of a generation accustomed to technology and self-care.
  • The advancements in technology have revolutionized fertility testing devices, making them more accurate, user-friendly, and cost-effective. This progress has expanded the market reach beyond clinics, empowering couples to take an active role in family planning. The rising awareness about fertility options and the normalization of discussions around reproductive health further contribute to the increasing adoption of these devices.

Increasing Developments and Advancements

  • The Fertility Testing Devices Market is poised to harness significant opportunities, primarily driven by the continuous stream of developments and advancements in this dynamic field. These ongoing innovations have the potential to reshape the landscape of fertility testing devices, offering improved accuracy, accessibility, and convenience for individuals and couples seeking to understand and manage their reproductive health.
  • One of the key opportunities lies in the advancement of technology. The integration of artificial intelligence (AI), machine learning, and data analytics into fertility testing devices has the potential to revolutionize the field. These technologies can enhance the precision and reliability of fertility predictions, enabling more accurate assessments of fertile windows, ovulation, and sperm quality. Moreover, AI-powered apps and wearable devices can provide personalized recommendations based on an individual's unique fertility patterns, optimizing the chances of conception.
  • Another promising development is the increasing availability of at-home testing options. Home fertility testing kits have gained popularity due to their convenience and privacy. The market is likely to see further expansion in this category, with new and improved testing kits offering comprehensive insights into reproductive health. Accessibility to fertility testing at home not only empowers individuals and couples but also reduces the barriers to seeking early fertility assessments.

 Global Fertility Testing Devices Market Segment Analysis:

Global Fertility Testing Devices Market Segmented on the basis of type, application, and end-users.

By Product Type, Male fertility segment is expected to dominate the market during the forecast period

  • Male fertility test segment dominated the fertility device market. These kits have gained prominence in recent years due to an increased focus on understanding and addressing male infertility issues. Traditionally, fertility testing is primarily centered around female-related assessments. However, there is now a growing realization that male factors contribute significantly to infertility in couples.
  • For instance, according to the Lancet report published in 2020, nearly 8-12% of couples globally are facing the problem of infertility, with the males being primary cause in around 50% of couples. The causes of male infertility are many. It may be due to any physical abnormality, it may be acquired, or it could be an idiopathic factor.

 By Distribution Channel, Online pharmacy segment held the largest share of 40% in 2022

  • The growth of online pharmacies has significantly impacted the accessibility and availability of fertility testing devices, contributing to the expansion of this segment in the market. Online pharmacies offer a convenient platform for individuals seeking fertility testing devices, providing a range of products that can be easily accessed from the comfort and privacy of one's home.
  • One key reason for the growth of fertility testing devices within online pharmacies is the anonymity and discretion they afford to customers. Reproductive health can be a sensitive topic, and individuals may prefer the confidentiality that online platforms offer when purchasing these devices. This aspect becomes particularly crucial for those who might feel uncomfortable discussing fertility concerns in a traditional brick-and-mortar setting.

Global Fertility Testing Devices Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America dominates the fertility testing devices market because of the rise in the prevalence of adolescent pregnancy and the rise in the awareness of pregnancy testing methods and improving fertility rates within the region.
  • Additionally, a high prevalence of lifestyle-related factors impacting fertility, such as stress and obesity, has driven the demand for these devices in North America. The presence of key market players, research and development initiatives, and favorable government policies have also contributed to the region's dominant position in the fertility testing devices market.

 Global Fertility Testing Devices Market Top Key Players:

  • Abbott Laboratories (United States)
  • Alere Inc. (United States)
  • Bayer AG (Germany)
  • Becton, Dickinson and Company (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Canon Inc. (Japan)
  • Chembio Diagnostics, Inc. (United States)
  • Church & Dwight Co., Inc. (United States)
  • Cooper Surgical, Inc. (United States)
  • Fujifilm Holdings Corporation (Japan)
  • Getz Pharma (India)
  • Guerbet (France)
  • I-Tech (Austria)
  • In Vitro Diagnostics (India)
  • Konica Minolta, Inc. (Japan)
  • Merck KGaA (Germany)
  • Natus Medical Incorporated (United States)
  • Nova Biomedical (United States)
  • Procter & Gamble (United States)
  • Quidel Corporation (United States)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare GmbH (Germany)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific, Inc. (United States)
  • Vitro Diagnostics, Inc. (United States)

Key Industry Developments in the Global Fertility Testing Devices Market:

In 2023, Clearblue launched the Clearblue Advanced Digital Ovulation Test, which is 99% accurate in detecting ovulation. The test also features a cycle tracker and a mobile app that can be used to track ovulation and other fertility markers.

In 2023, Modern Fertility offers a variety of at-home fertility tests, including the Modern Fertility Hormone Test and the Modern Fertility Ovulation Kit. The company's tests are designed to be easy to use and provide accurate results.

 

 Global Fertility Testing Devices Market

Base Year:

2022

Forecast Period:

2023-2030

Historical Data:

2017 to 2022

Market Size in 2022:

USD 659.09 Bn.

Forecast Period 2023-30 CAGR:

6.6%

Market Size in 2030:

USD 1099.01Bn.

Segments Covered:

By Product Type

  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Test Kits

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Mode of Purchase

  • Over the Counter
  • Prescription Based

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing first-time pregnancy age

Key Market Restraints:

  • Limited Accuracy Of Some Fertility Testing Methods

Key Opportunities:

  • Increasing Developments and Advancements

Companies Covered in the report:

  • Abbott Laboratories, Alere Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canon Inc and other major players

 

  1. INTRODUCTION
    1. RESEARCH OBJECTIVES
    2. RESEARCH METHODOLOGY
    3. RESEARCH PROCESS
    4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
    5. MARKET SEGMENTATION
  2. EXECUTIVE SUMMARY
  3. MARKET OVERVIEW
  4. GROWTH OPPORTUNITIES BY SEGMENT
  5. MARKET LANDSCAPE
    1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
    2. INDUSTRY VALUE CHAIN ANALYSIS
    3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    4. MARKET TREND ANALYSIS
    5. REGULATORY LANDSCAPE
    6. PESTLE ANALYSIS
    7. PRICE TREND ANALYSIS
    8. PATENT ANALYSIS
    9. TECHNOLOGY EVALUATION
    10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
      1. Geopolitical Market Disruptions
      2. Supply Chain Disruptions
      3. Instability in Emerging Markets
    11. ECOSYSTEM
  6. FERTILITY TESTING DEVICESMARKET BY PRODUCT TYPE (2016-2030)
    1. FERTILITY TESTING DEVICESMARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. OVULATION PREDICTION KITS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. FERTILITY MONITORS
    5. MALE FERTILITY TEST KITS
  7. FERTILITY TESTING DEVICESMARKET BY DISTRIBUTION CHANNEL (2016-2030)
    1. FERTILITY TESTING DEVICESMARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. HOSPITAL PHARMACY
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. RETAIL PHARMACY
    5. ONLINE PHARMACY
  8. FERTILITY TESTING DEVICESMARKET BY MODE OF PURCHASE (2016-2030)
    1. FERTILITY TESTING DEVICESMARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. OVER THE COUNTER
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. PRESCRIPTION BASED
    5. MODE OF PURCHASEC
    6. MODE OF PURCHASED
    7. MODE OF PURCHASEE
    8. MODE OF PURCHASEF
  9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Fertility Testing DevicesMarket Share By Manufacturer (2022)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
    2. ABBOTT LABORATORIES
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
    3.  Alere Inc.
    4. Bayer AG
    5. Becton, Dickinson and Company
    6. Bio-Rad Laboratories, Inc.
    7. Canon Inc.
    8. Chembio Diagnostics, Inc.
    9. Church & Dwight Co., Inc.
    10. Cooper Surgical, Inc.
    11. Fujifilm Holdings Corporation
    12. Getz Pharma
    13. Guerbet
    14. I-Tech
    15. In Vitro Diagnostics
    16. Konica Minolta, Inc.
    17. Merck KGaA
    18. Natus Medical Incorporated
    19. Nova Biomedical
    20. Procter & Gamble
    21. Quidel Corporation
    22. Roche Diagnostics
  10. GLOBAL FERTILITY TESTING DEVICESMARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Product Type
      4. Historic And Forecasted Market Size By Distribution Channel
      5. Historic And Forecasted Market Size By Mode of Purchase
      6. Historic And Forecasted Market Size By Country
        1. USA
        2. Canada
        3. Mexico
    3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Russia
        2. Bulgaria
        3. The Czech Republic
        4. Hungary
        5. Poland
        6. Romania
        7. Rest Of Eastern Europe
    4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Germany
        2. United Kingdom
        3. France
        4. The Netherlands
        5. Italy
        6. Spain
        7. Rest Of Western Europe
    5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Malaysia
        6. Thailand
        7. Vietnam
        8. The Philippines
        9. Australia
        10. New-Zealand
        11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Turkey
        2. Bahrain
        3. Kuwait
        4. Saudi Arabia
        5. Qatar
        6. UAE
        7. Israel
        8. South Africa
    7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
  11. INVESTMENT ANALYSIS
  12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

 

 Global Fertility Testing Devices Market

Base Year:

2022

Forecast Period:

2023-2030

Historical Data:

2017 to 2022

Market Size in 2022:

USD 659.09 Bn.

Forecast Period 2023-30 CAGR:

6.6%

Market Size in 2030:

USD 1099.01Bn.

Segments Covered:

By Product Type

  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Test Kits

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Mode of Purchase

  • Over the Counter
  • Prescription Based

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing first-time pregnancy age

Key Market Restraints:

  • Limited Accuracy Of Some Fertility Testing Methods

Key Opportunities:

  • Increasing Developments and Advancements

Companies Covered in the report:

  • Abbott Laboratories, Alere Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canon Inc and other major players

 

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. FERTILITY TESTING DEVICES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. FERTILITY TESTING DEVICES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. FERTILITY TESTING DEVICES MARKET COMPETITIVE RIVALRY
TABLE 005. FERTILITY TESTING DEVICES MARKET THREAT OF NEW ENTRANTS
TABLE 006. FERTILITY TESTING DEVICES MARKET THREAT OF SUBSTITUTES
TABLE 007. FERTILITY TESTING DEVICES MARKET BY PRODUCT TYPE
TABLE 008. OVULATION PREDICTION KITS MARKET OVERVIEW (2016-2030)
TABLE 009. FERTILITY MONITORS MARKET OVERVIEW (2016-2030)
TABLE 010. MALE FERTILITY TEST KITS MARKET OVERVIEW (2016-2030)
TABLE 011. FERTILITY TESTING DEVICES MARKET BY DISTRIBUTION CHANNEL
TABLE 012. HOSPITAL PHARMACY MARKET OVERVIEW (2016-2030)
TABLE 013. RETAIL PHARMACY MARKET OVERVIEW (2016-2030)
TABLE 014. ONLINE PHARMACY MARKET OVERVIEW (2016-2030)
TABLE 015. FERTILITY TESTING DEVICES MARKET BY MODE OF PURCHASE
TABLE 016. OVER THE COUNTER MARKET OVERVIEW (2016-2030)
TABLE 017. PRESCRIPTION BASED MARKET OVERVIEW (2016-2030)
TABLE 018. NORTH AMERICA FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 019. NORTH AMERICA FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 020. NORTH AMERICA FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 021. N FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 022. EASTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 023. EASTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 024. EASTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 025. FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 026. WESTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 027. WESTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 028. WESTERN EUROPE FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 029. FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 030. ASIA PACIFIC FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 031. ASIA PACIFIC FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 032. ASIA PACIFIC FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 033. FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 034. MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 035. MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 036. MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 037. FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 038. SOUTH AMERICA FERTILITY TESTING DEVICES MARKET, BY PRODUCT TYPE (2016-2030)
TABLE 039. SOUTH AMERICA FERTILITY TESTING DEVICES MARKET, BY DISTRIBUTION CHANNEL (2016-2030)
TABLE 040. SOUTH AMERICA FERTILITY TESTING DEVICES MARKET, BY MODE OF PURCHASE (2016-2030)
TABLE 041. FERTILITY TESTING DEVICES MARKET, BY COUNTRY (2016-2030)
TABLE 042. SWISS PRECISION MACHINING: SNAPSHOT
TABLE 043. SWISS PRECISION MACHINING: BUSINESS PERFORMANCE
TABLE 044. SWISS PRECISION MACHINING: PRODUCT PORTFOLIO
TABLE 045. SWISS PRECISION MACHINING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. LLC (SWITZERLAND): SNAPSHOT
TABLE 046. LLC (SWITZERLAND): BUSINESS PERFORMANCE
TABLE 047. LLC (SWITZERLAND): PRODUCT PORTFOLIO
TABLE 048. LLC (SWITZERLAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. CHURCH & DWIGHT CO.: SNAPSHOT
TABLE 049. CHURCH & DWIGHT CO.: BUSINESS PERFORMANCE
TABLE 050. CHURCH & DWIGHT CO.: PRODUCT PORTFOLIO
TABLE 051. CHURCH & DWIGHT CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. INC. (US): SNAPSHOT
TABLE 052. INC. (US): BUSINESS PERFORMANCE
TABLE 053. INC. (US): PRODUCT PORTFOLIO
TABLE 054. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. PRESTIGE CONSUMER HEALTHCARE INC. (US): SNAPSHOT
TABLE 055. PRESTIGE CONSUMER HEALTHCARE INC. (US): BUSINESS PERFORMANCE
TABLE 056. PRESTIGE CONSUMER HEALTHCARE INC. (US): PRODUCT PORTFOLIO
TABLE 057. PRESTIGE CONSUMER HEALTHCARE INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. BIOZHENA CORPORATION (US): SNAPSHOT
TABLE 058. BIOZHENA CORPORATION (US): BUSINESS PERFORMANCE
TABLE 059. BIOZHENA CORPORATION (US): PRODUCT PORTFOLIO
TABLE 060. BIOZHENA CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. FAIRHAVEN HEALTH (US): SNAPSHOT
TABLE 061. FAIRHAVEN HEALTH (US): BUSINESS PERFORMANCE
TABLE 062. FAIRHAVEN HEALTH (US): PRODUCT PORTFOLIO
TABLE 063. FAIRHAVEN HEALTH (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. FERTILITY FOCUS LIMITED (UK): SNAPSHOT
TABLE 064. FERTILITY FOCUS LIMITED (UK): BUSINESS PERFORMANCE
TABLE 065. FERTILITY FOCUS LIMITED (UK): PRODUCT PORTFOLIO
TABLE 066. FERTILITY FOCUS LIMITED (UK): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. GERATHERM MEDICAL AG (GERMANY): SNAPSHOT
TABLE 067. GERATHERM MEDICAL AG (GERMANY): BUSINESS PERFORMANCE
TABLE 068. GERATHERM MEDICAL AG (GERMANY): PRODUCT PORTFOLIO
TABLE 069. GERATHERM MEDICAL AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. THE BETTY MILLS COMPANY: SNAPSHOT
TABLE 070. THE BETTY MILLS COMPANY: BUSINESS PERFORMANCE
TABLE 071. THE BETTY MILLS COMPANY: PRODUCT PORTFOLIO
TABLE 072. THE BETTY MILLS COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. INC. (US): SNAPSHOT
TABLE 073. INC. (US): BUSINESS PERFORMANCE
TABLE 074. INC. (US): PRODUCT PORTFOLIO
TABLE 075. INC. (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. UEBE MEDICAL GMBH (GERMANY): SNAPSHOT
TABLE 076. UEBE MEDICAL GMBH (GERMANY): BUSINESS PERFORMANCE
TABLE 077. UEBE MEDICAL GMBH (GERMANY): PRODUCT PORTFOLIO
TABLE 078. UEBE MEDICAL GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. ADVACARE PHARMA (US): SNAPSHOT
TABLE 079. ADVACARE PHARMA (US): BUSINESS PERFORMANCE
TABLE 080. ADVACARE PHARMA (US): PRODUCT PORTFOLIO
TABLE 081. ADVACARE PHARMA (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. BABYSTART (UK): SNAPSHOT
TABLE 082. BABYSTART (UK): BUSINESS PERFORMANCE
TABLE 083. BABYSTART (UK): PRODUCT PORTFOLIO
TABLE 084. BABYSTART (UK): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. VALLEY ELECTRONICS AG (GERMANY): SNAPSHOT
TABLE 085. VALLEY ELECTRONICS AG (GERMANY): BUSINESS PERFORMANCE
TABLE 086. VALLEY ELECTRONICS AG (GERMANY): PRODUCT PORTFOLIO
TABLE 087. VALLEY ELECTRONICS AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. MIRA CARE (US): SNAPSHOT
TABLE 088. MIRA CARE (US): BUSINESS PERFORMANCE
TABLE 089. MIRA CARE (US): PRODUCT PORTFOLIO
TABLE 090. MIRA CARE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 091. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 092. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 093. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. FERTILITY TESTING DEVICES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. FERTILITY TESTING DEVICES MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. OVULATION PREDICTION KITS MARKET OVERVIEW (2016-2030)
FIGURE 013. FERTILITY MONITORS MARKET OVERVIEW (2016-2030)
FIGURE 014. MALE FERTILITY TEST KITS MARKET OVERVIEW (2016-2030)
FIGURE 015. FERTILITY TESTING DEVICES MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 016. HOSPITAL PHARMACY MARKET OVERVIEW (2016-2030)
FIGURE 017. RETAIL PHARMACY MARKET OVERVIEW (2016-2030)
FIGURE 018. ONLINE PHARMACY MARKET OVERVIEW (2016-2030)
FIGURE 019. FERTILITY TESTING DEVICES MARKET OVERVIEW BY MODE OF PURCHASE
FIGURE 020. OVER THE COUNTER MARKET OVERVIEW (2016-2030)
FIGURE 021. PRESCRIPTION BASED MARKET OVERVIEW (2016-2030)
FIGURE 022. NORTH AMERICA FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 023. EASTERN EUROPE FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 024. WESTERN EUROPE FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 025. ASIA PACIFIC FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 026. MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)
FIGURE 027. SOUTH AMERICA FERTILITY TESTING DEVICES MARKET OVERVIEW BY COUNTRY (2016-2030)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Global Fertility Testing Devices Market research report?

The forecast period in the Global Fertility Testing Devices Market research report is 2023-2030.

Who are the key players in the Global Fertility Testing Devices Market?

Abbott Laboratories, Alere Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Canon Inc., Chembio Diagnostics, Inc., Church & Dwight Co., Inc., Cooper Surgical, Inc., Fujifilm Holdings Corporation, Getz Pharma, Guerbet, I-Tech, In Vitro Diagnostics, Konica Minolta, Inc., Merck KGaA, Natus Medical Incorporated, Nova Biomedical, Procter & Gamble ,Quidel Corporation, Roche Diagnostics, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific, Inc., Vitro Diagnostics, Inc.

What are the segments of the Global Fertility Testing Devices Market?

The Fertility Testing Devices Market is segmented into Product Type, Distribution Channel, Mode of Purchase, and region. By Product Type, the market is categorized into Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Test Kits. By Distribution Channel, the market is categorized into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. By Mode of Purchase, the market is categorized into Over-the-counter and Prescription Based. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Global Fertility Testing Devices Market?

Fertility Testing Devices refer to a diverse range of medical instruments, tools, and kits designed to assess and monitor an individual's reproductive health and fertility potential. These devices are crucial for both men and women who are trying to conceive, as they provide valuable insights into various aspects of fertility, aiding in family planning and addressing infertility issues.

How big is the Global Fertility Testing Devices Market?

Global Fertility Testing Devices Market Size Was Valued at USD 659.09 Million In 2022 And Is Projected to Reach USD 1099.01 Million By 2030, Growing at A CAGR of 6.6% From 2022 To 2030.